ImmunoSPdb: an archive of immunosuppressive peptides
- PMID: 30753476
- PMCID: PMC6367516
- DOI: 10.1093/database/baz012
ImmunoSPdb: an archive of immunosuppressive peptides
Abstract
Immunosuppression proved as a captivating therapy in several autoimmune disorders, asthma as well as in organ transplantation. Immunosuppressive peptides are specific for reducing efficacy of immune system with wide range of therapeutic implementations. `ImmunoSPdb' is a comprehensive, manually curated database of around 500 experimentally verified immunosuppressive peptides compiled from 79 research article and 32 patents. The current version comprises of 553 entries providing extensive information including peptide name, sequence, chirality, chemical modification, origin, nature of peptide, its target as well as mechanism of action, amino acid frequency and composition, etc. Data analysis revealed that most of the immunosuppressive peptides are linear (91%), are shorter in length i.e. up to 20 amino acids (62%) and have L form of amino acids (81%). About 30% peptide are either chemically modified or have end terminal modification. Most of the peptides either are derived from proteins (41%) or naturally (27%) exist. Blockage of potassium ion channel (24%) is one a major target for immunosuppressive peptides. In addition, we have annotated tertiary structure by using PEPstrMOD and I-TASSER. Many user-friendly, web-based tools have been integrated to facilitate searching, browsing and analyzing the data. We have developed a user-friendly responsive website to assist a wide range of users.
Figures




Similar articles
-
TopicalPdb: A database of topically delivered peptides.PLoS One. 2018 Feb 12;13(2):e0190134. doi: 10.1371/journal.pone.0190134. eCollection 2018. PLoS One. 2018. PMID: 29432422 Free PMC article.
-
CPPsite: a curated database of cell penetrating peptides.Database (Oxford). 2012 Mar 7;2012:bas015. doi: 10.1093/database/bas015. Print 2012. Database (Oxford). 2012. PMID: 22403286 Free PMC article.
-
THPdb: Database of FDA-approved peptide and protein therapeutics.PLoS One. 2017 Jul 31;12(7):e0181748. doi: 10.1371/journal.pone.0181748. eCollection 2017. PLoS One. 2017. PMID: 28759605 Free PMC article.
-
Amino acid modifications for conformationally constraining naturally occurring and engineered peptide backbones: Insights from the Protein Data Bank.Biopolymers. 2018 Aug;109(10):e23230. doi: 10.1002/bip.23230. Epub 2018 Oct 25. Biopolymers. 2018. PMID: 30368772 Review.
-
SheddomeDB 2023: A Revision of an Ectodomain Shedding Database Based on a Comprehensive Literature Review and Online Resources.J Proteome Res. 2023 Aug 4;22(8):2570-2576. doi: 10.1021/acs.jproteome.3c00001. Epub 2023 Jul 17. J Proteome Res. 2023. PMID: 37458416 Free PMC article. Review.
References
-
- Lerner A., Jeremias P. and Matthias T. (2016) The world incidence and prevalence of autoimmune diseases is increasing. Int. J. Celiac Dis., 3, 151–155.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources